Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST
Clinical trial NCT02847429 · UNKNOWN
Trial details
- NCT number
- NCT02847429
- Sponsor
- Arog Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2021-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.